B

Active Director Director DIN 10965311
DIN 10965311 First appointment Feb 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Balaji

Data last updated:

Balaji is a Director at Teslee Biosciences Private Limited (since 2025). The company operates in Biotechnology.

DIN 10965311
Primary Designation Director
Industry Biotechnology
First Appointment 22 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Teslee Biosciences Private Limited U46497TN2025PTC177289
Director22 Feb 20252025Active

Board colleagues of Balaji

NameDINCompanyDesignation
Etheeraj Hemanth10965312Teslee Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Teslee Biosciences Private Limited
Premium access

Shareholding and investment profile for Balaji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balaji

Balaji currently holds 1 directorship: Teslee Biosciences Private Limited (Director, since 22 Feb 2025).

Balaji was first appointed on 22 Feb 2025 as Director at Teslee Biosciences Private Limited.

The current boards of Balaji's companies include Etheeraj Hemanth (Teslee Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available